
    
      OBJECTIVES:

        -  Compare the quality of life of patients with advanced non-small cell lung cancer treated
           with vinorelbine, gemcitabine, and docetaxel vs paclitaxel and carboplatin on protocol
           JMTO-LC00-03.

      OUTLINE: This is a multicenter study. Patients receive treatment on protocol JMTO-LC00-03.

      Quality of life is assessed using the Functional Assessment of Cancer Therapy-Lung (FACT-L),
      FACT-Taxane, and Functional Assessment of Chronic Illness Therapy-Spirituality (FACIT-Sp)
      questionnaires at baseline, weeks 9 and 18, and at the completion of treatment.

      PROJECTED ACCRUAL: A total of 80 patients will be accrued for this study.
    
  